FDA Approved Biologics and Pending Applications
tocilizumab
BL 125276 [BL 125472]
alteplase
BL 103172
bevacizumab
BL 125085
glofitamab-gxbm
BL 761309
satralizumab
BL 761149
obinutuzumab
BL 125486
emicizumab-kxwh
BL 761083
trastuzumab; hyaluronidase-oysk
BL 761106
trastuzumab
BL 103792
ado-trastuzumab emtansine
BL 125427
ranibizumab
BL 125156
mosunetuzumab-axgb
BL 761263
somatropin
BL 020522
somatropin (rDNA origin)
BL 019676
ocrelizumab; hyaluronidase-ocsq
BL 761053
ocrelizumab
BL 761053
pertuzumab
BL 125409
pertuzumab; trastuzumab; hyaluronidase-zzxf
BL 761170
crovalimab-akkz
BL 761388
polatuzumab vedotin-piiq
BL 761121
dornase alfa
BL 103532
rituximab; hyaluronidase
BL 761064
rituximab
BL 103705 [BL 103737]
ranobizumab
BL 761197
atezolizumab and hyaluronidase-tqjs
BL 761347
atezolizumab
BL 761034
tenecteplase
BL 103909
faricimab-svoa
aBL 761235
omalizumab
BL 103976
Inter Partes Review Proceedings
GENENTECH CABILLYIPR2015-01624IPR2016-00383IPR2016-00460IPR2016-00710IPR2016-01373IPR2017-00047KADCYLAIPR2014-00676IPR2014-00842KEYTRUDAPGR2021-00036PGR2021-00039RITUXANIPR2015-00415IPR2015-00417IPR2015-01733IPR2015-01744IPR2016-01614IPR2016-01667IPR2017-01115IPR2017-01227IPR2017-01229IPR2017-01230IPR2017-01923IPR2017-02036IPR2017-02042IPR2017-02126IPR2017-02127IPR2018-01019TALTZPGR2019-00043ACTEMRA / CT-P47IPR2022-00578IPR2022-00579ACTEMRA / TYENNEIPR2021-01288IPR2021-01542AVASTIN / ZIRABEVIPR2016-01771IPR2018-00373HERCEPTIN / HERZUMAIPR2017-00959IPR2017-01121IPR2017-01122IPR2017-01139IPR2017-01140IPR2017-01373IPR2017-01374HERCEPTIN / OGIVRIIPR2016-01693IPR2016-01694HERCEPTIN / ONTRUZANTIPR2017-01958IPR2017-01959IPR2017-01960IPR2017-02139IPR2017-02140IPR2018-00192HERCEPTIN / TRAZIMERAIPR2016-01837IPR2017-00731IPR2017-00737IPR2017-00739IPR2017-00804IPR2017-00805IPR2017-01488IPR2017-01489IPR2017-01726IPR2017-01727IPR2017-02019IPR2017-02020IPR2017-02063IPR2018-00016IPR2018-00330IPR2018-00331RITUXAN / RIXATHONIPR2017-02036IPR2017-02042RITUXAN / RUXIENCEIPR2017-01115IPR2017-01923IPR2017-02126IPR2017-02127RITUXAN / TRUXIMAIPR2015-01733IPR2015-01744IPR2016-01614IPR2016-01667IPR2017-01227IPR2017-01229IPR2017-01230IPR2018-01019
U.S. Patent Litigations
ELITEK2:15-cv-01143 (W.D. Wash.)HEMLIBRA1:17-cv-00509 (D. Del.)HERCEPTIN1:10-cv-00799 (D. Del.)1:17-cv-01672 (D. Del.)1:18-cv-00095 (D. Del.)1:18-cv-00924 (D. Del.)1:18-cv-01025 (D. Del.)1:18-cv-01363 (D. Del.)1:22-cv-00145 (D. Del.)3:08-cv-04909 (N.D. Cal.)3:09-cv-04919 (N.D. Cal.)3:22-cv-00809 (S.D. Cal.)4:18-cv-00274 (N.D. Cal.)5:10-cv-02037 (C.D. Cal.)5:10-cv-04255 (C.D. Cal.)KADCYLA1:14-cv-00287 (N.D. Ga.)5:15-cv-01238 (N.D. Cal.)TALTZ3:18-cv-01518 (S.D. Cal.)ZALTRAP7:11-cv-09463 (S.D.N.Y.)ACTEMRA / TOFIDENCE1:23-cv-11573 (D. Mass.)ACTIVASE / CATHFLO ACTIVASE / AVASTIN / HERCEPTIN / PULMOZYME / RITUXAN / TNKASE / XOLAIR3:08-cv-04909 (N.D. Cal.)3:09-cv-04919 (N.D. Cal.)AVASTIN / FKB2382:20-cv-00361 (E.D. Tex.)AVASTIN / MVASI1:17-cv-00165 (D. Del.)1:17-cv-01407 (D. Del.)1:17-cv-01471 (D. Del.)1:19-cv-00602 (D. Del.)2:17-cv-07349 (C.D. Cal.)AVASTIN / MVASI / GENENTECH CABILLY1:17-cv-01407 (D. Del.)1:17-cv-01471 (D. Del.)1:19-cv-00602 (D. Del.)2:17-cv-07349 (C.D. Cal.)AVASTIN / SB81:20-cv-00859 (D. Del.)AVASTIN / ZIRABEV1:19-cv-00638 (D. Del.)BENLYSTA / GENENTECH CABILLY1:11-cv-00082 (D. Del.) 1:11-cv-00328 (D. Del.) 2:11-cv-03065 (C.D. Cal.)2:11-cv-06519 (C.D. Cal.)2:11-cv-06594 (C.D. Cal.)CAMPATH / LEMTRADA / GENENTECH CABILLY2:15-cv-09991 (C.D. Cal.) ERBITUX / GENENTECH CABILLY2:13-cv-05400 (N.D. Cal.)2:13-cv-07248 (C.D. Cal.)3:13-cv-02045 (N.D. Cal.)4:13-cv-00919 (N.D. Cal.)ERBITUX / GENENTECH CABILLY / YERVOY2:13-cv-05400 (N.D. Cal.)3:13-cv-02045 (N.D. Cal.)HERCEPTIN / HERCEPTIN HYLECTA / PERJETA / PHESGO1:22-cv-00145 (D. Del.)HERCEPTIN / HERZUMA / GENENTECH CABILLY1:18-cv-00095 (D. Del.)1:18-cv-01025 (D. Del.)4:18-cv-00274 (N.D. Cal.)HERCEPTIN / KANJINTI / GENENTECH CABILLY1:18-cv-00924 (D. Del.)HERCEPTIN / ONTRUZANT / GENENTECH CABILLY1:18-cv-01363 (D. Del.)HERCEPTIN / TRAZIMERA / GENENTECH CABILLY1:17-cv-01672 (D. Del.)HERCEPTIN / TX-053:22-cv-00809 (S.D. Cal.)OPDIVO / TECENTRIQ1:17-cv-01027 (D. Del.)PRALUENT / GENENTECH CABILLY2:15-cv-05685 (C.D. Cal.)REOPRO / GENENTECH CABILLY2:08-cv-03573 (C.D. Cal.)RITUXAN / DRL_RI1:23-cv-22485 (D.N.J.)RITUXAN / RIXATHON / GENENTECH CABILLY1:17-cv-13507 (D.N.J.)RITUXAN / TRUXIMA / GENENTECH CABILLY1:18-cv-00574 (D.N.J.)1:18-cv-11553 (D.N.J.)4:18-cv-00276 (N.D. Cal.)